J.W. Cole Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.85M Buy
+30,495
New +$4.02M 0.07% 307
2026
Q1
Sell
-31,040
Closed -$3.55M 1031
2025
Q4
$3.55M Buy
31,040
+562
+2% +$68.3K 0.09% 232
2025
Q3
$3.38M Buy
30,478
+7,397
+32% +$841K 0.06% 290
2025
Q2
$2.56M Buy
23,081
+1,354
+6% +$144K 0.05% 336
2025
Q1
$2.43M Buy
21,727
+8,130
+60% +$839K 0.08% 267
2024
Q4
$1.26M Buy
13,597
+135
+1% +$12.2K 0.05% 350
2024
Q3
$1.13M Sell
13,462
-1,777
-12% -$136K 0.05% 363
2024
Q2
$1.05M Sell
15,239
-26,497
-63% -$1.77M 0.05% 347
2024
Q1
$3.06M Sell
41,736
-146
-0.3% -$11.2K 0.15% 148
2023
Q4
$3.39M Buy
41,882
+2,638
+7% +$205K 0.2% 119
2023
Q3
$2.94M Buy
39,244
+3,985
+11% +$307K 0.22% 111
2023
Q2
$2.72M Buy
35,259
+474
+1% +$37.8K 0.19% 129
2023
Q1
$2.89M Buy
34,785
+91
+0.3% +$7.54K 0.21% 124
2022
Q4
$2.98M Sell
34,694
-5,656
-14% -$448K 0.23% 114
2022
Q3
$2.49M Buy
40,350
+1,480
+4% +$93.3K 0.21% 119
2022
Q2
$2.4M Buy
38,870
+574
+1% +$35.5K 0.19% 129
2022
Q1
$2.28M Buy
38,296
+4,951
+15% +$316K 0.15% 159
2021
Q4
$2.42M Buy
33,345
+2,085
+7% +$144K 0.16% 156
2021
Q3
$2.18M Buy
31,260
+93
+0.3% +$6.53K 0.16% 94
2021
Q2
$2.15M Buy
31,167
+876
+3% +$58.5K 0.17% 141
2021
Q1
$1.96M Buy
30,291
+367
+1% +$23.7K 0.19% 131
2020
Q4
$1.74M Sell
29,924
-3,992
-12% -$241K 0.18% 136
2020
Q3
$2.14M Buy
33,916
+5,539
+20% +$384K 0.16% 144
2020
Q2
$2.18M Buy
28,377
+13,467
+90% +$1.03M 0.33% 93
2020
Q1
$1.11M Sell
14,910
-17,490
-54% -$1.21M 2.15% 8
2019
Q4
$2.1M Buy
+32,400
New +$2.11M 0.27% 101

Other funds holding GILD

J.W. Cole Advisors's GILD Position: Q2 2026 in Review

J.W. Cole Advisors opened a new position in Gilead Sciences (GILD) in Q2 2026: 30,495 shares worth $3.85M. The stake represents 0.07% of the portfolio and ranks #307 among its holdings. This is a return to the name: J.W. Cole Advisors previously reported a position in GILD as recently as Q4 2025.

J.W. Cole Advisors first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • J.W. Cole Advisors held 30,495 shares of Gilead Sciences worth $3.85M as of Q2 2026.
  • Gilead Sciences was a new J.W. Cole Advisors position in Q2 2026.
  • Gilead Sciences made up 0.07% of J.W. Cole Advisors's portfolio in Q2 2026, its #307 holding.
  • J.W. Cole Advisors first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.